Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

High RiskFDA Device
Medical Devices/Home Healthcare

iBOT Personal Mobility Device Recalled for Tipping Hazard

Agency Publication Date: June 12, 2025
Share:
Sign in to monitor this recall

Summary

Mobius Mobility LLC has recalled 442 units of the iBOT Personal Mobility Device (PMD) equipped with software version 01.05.24. This recall was initiated due to a software issue that could cause the device to tip over while operating in Balance Mode. No injuries or incidents have been reported to date. Consumers should stop using the device in Balance Mode and contact the manufacturer or their mobility distributor to arrange for a software update.

Risk

The software defect can cause the mobility device to unexpectedly tip over when the user is in Balance Mode, posing a significant fall risk and potential for serious injury.

What You Should Do

  1. This recall involves the iBOT Personal Mobility Device (PMD), a specialized motorized wheelchair capable of self-balancing, running software version 01.05.24.
  2. Affected devices include those with serial numbers such as 0001108, 0001422, 0001438, and 0001496. See the Affected Products section below for the full list of affected codes.
  3. Stop using the device in Balance Mode immediately to avoid the risk of the device tipping over.
  4. Contact Mobius Mobility LLC or your authorized mobility distributor to arrange for a software correction or repair.
  5. Call the FDA at 1-888-463-6332 (1-888-INFO-FDA) for additional information regarding medical device recalls.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider, or return the product to the place of purchase for a refund or replacement
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Stop using and throw the product away.

Affected Products

Product: iBOT Personal Mobility Device (PMD)
Variants: Software version 01.05.24
Serial Numbers:
0001108
0001110
0001121
0001123
0001128
0001136
0001137
0001422
0001438
0001496
0001505
0001508
0001516
0001517
0001519
UDI:
00857584008010

Quantity affected: 442 units.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 96834
Status: Active
Manufacturer: Mobius Mobility LLC
Sold By: Mobius Mobility LLC; Authorized Mobility Distributors
Manufactured In: United States
Units Affected: 442 units
Distributed To: California, Colorado, Florida, Georgia, Indiana, North Carolina, New Jersey, Ohio, Puerto Rico, Rhode Island, Tennessee, Texas, Virginia

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.